27 July 2022: Meta-Analysis
The Prognostic Value of Periostin Expression in Non-Small Cell Lung Cancer: A Meta-Analysis
Mengjie Li 1234ABCDEFG* , Guangzhi Ma 1ABCDEF* , Xuebing Li 2ACFG* , Qinghua Zhou 12ACFG*DOI: 10.12659/MSM.936898
Med Sci Monit 2022; 28:e936898
Figure 4 Begg’s publication bias plots of the studies that reported the correlation between periostin expression and NSCLC survival on OS. Each study is represented by 1 circle. The horizontal line represents the pooled effect estimate. STATA (version 13.1; Stata Corporation, College Station, TX, USA) was used.